Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005714 |
---|---|
Receipt number | R000006754 |
Scientific Title | A Phase II trial of immunotherapy with an anti-PD-1 antibody in advanced / relapsed, Platinum - resistant Ovarian Cancer |
Date of disclosure of the study information | 2011/09/15 |
Last modified on | 2015/02/12 09:49:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/06/03 15:32:02 | ||
2 | Update | 2011/10/19 19:43:32 | Recruitment status |
|
3 | Update | 2013/02/20 20:48:50 | Last name of lead principal investigator Last name of lead principal investigator Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2013/02/20 20:50:35 | Name of person sending information |
|
5 | Update | 2013/06/14 11:28:06 | Last follow-up date |
|
6 | Update | 2013/12/03 22:01:27 | TEL TEL |
|
7 | Update | 2013/12/24 22:52:57 | Public title |
|
8 | Update | 2013/12/24 22:53:28 | Narrative objectives1 |
|
9 | Update | 2014/03/14 19:02:13 | Recruitment status |
|
10 | Update | 2015/02/12 09:49:51 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |